Cargando…
Smartphone and Wearable Sensors for the Estimation of Facioscapulohumeral Muscular Dystrophy Disease Severity: Cross-sectional Study
BACKGROUND: Facioscapulohumeral muscular dystrophy (FSHD) is a progressive neuromuscular disease. Its slow and variable progression makes the development of new treatments highly dependent on validated biomarkers that can quantify disease progression and response to drug interventions. OBJECTIVE: We...
Autores principales: | Zhuparris, Ahnjili, Maleki, Ghobad, Koopmans, Ingrid, Doll, Robert J, Voet, Nicoline, Kraaij, Wessel, Cohen, Adam, van Brummelen, Emilie, De Maeyer, Joris H, Groeneveld, Geert Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131943/ https://www.ncbi.nlm.nih.gov/pubmed/36920465 http://dx.doi.org/10.2196/41178 |
Ejemplares similares
-
Objective Monitoring of Facioscapulohumeral Dystrophy During Clinical Trials Using a Smartphone App and Wearables: Observational Study
por: Maleki, Ghobad, et al.
Publicado: (2022) -
A smartphone- and wearable-based biomarker for the estimation of unipolar depression severity
por: Zhuparris, Ahnjili, et al.
Publicado: (2023) -
Machine Learning Techniques for Developing Remotely Monitored Central Nervous System Biomarkers Using Wearable Sensors: A Narrative Literature Review
por: ZhuParris, Ahnjili, et al.
Publicado: (2023) -
Facioscapulohumeral muscular dystrophy and respiratory failure; what about the diaphragm?
por: Hazenberg, A., et al.
Publicado: (2014) -
Treatment of facioscapulohumeral muscular dystrophy with Denosumab
por: Lefkowitz, Stanley S., et al.
Publicado: (2012)